Article
ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in…
bioRxiv · 2020 · Turan Tufan
Key facts
| Title | ISL2 is an epigenetically silenced tumor suppressor and regulator of metabolism in pancreatic cancer |
|---|---|
| First author | Turan Tufan |
| Journal | bioRxiv |
| Published | May 26, 2020 |
| DOI | 10.1101/2020.05.23.112839 |
| Devices mentioned | BK110039, K103302, K800781 |
| Product codes mentioned | JJH, KIT, LXG, NDS, NJT, OOI, PFF, PFT, KIS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1